Company Filing History:
1 out of 94 
1 out of 2 Years Active: 2022
Title: Iris Mathijs: Innovator in Targeting Pancreatic Beta Cells
Introduction
Iris Mathijs, a pioneering inventor based in Bambrugge, Belgium, has made significant contributions to the field of biomedical research. With a focus on pancreatic beta cells, her innovative work has the potential to transform methods of diagnosing and treating various conditions linked to these critical cells. She holds one patent that underscores her expertise and commitment to advancing health sciences.
Latest Patents
Iris Mathijs' patent is titled "Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells." This invention focuses on identifying a specific biomarker located in the plasma membrane of pancreatic beta cells. This unique biomarker serves as an excellent candidate for imaging and targeting strategies that aim to study the pancreatic beta cell mass in the context of health and diseases such as Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), pancreatic cancers, obesity, islet transplantation, and beta cell regeneration.
Career Highlights
Throughout her career, Iris Mathijs has gained invaluable experience while working with leading research institutions, notably the Université Libre de Bruxelles and Vrije Universiteit Brussel. Her work at these prestigious institutions has allowed her to collaborate on various projects that enhance the understanding of pancreatic health and disease.
Collaborations
Iris has had the privilege of working alongside distinguished colleagues such as Eizirik Decio Laks and Alexander Balhuizen. Their collaborative efforts have contributed to a broader understanding of pancreatic beta cell dynamics and the implications for therapy and diagnostics in diabetes and related conditions.
Conclusion
Iris Mathijs exemplifies the innovative spirit in medical research and technology. Her patent for a biomarker expressed in pancreatic beta cells not only showcases her inventiveness but also serves as a foundation for future research and therapeutic strategies. As she continues to advance her work in this crucial area, her contributions are sure to leave a lasting impact on the field of diabetes research and treatment.